Cargando…

High‐density lipoprotein cholesterol levels are associated with major adverse cardiovascular events in male but not female patients with hypertension

BACKGROUND: The relationship between high‐density lipoprotein cholesterol (HDL‐C) levels and major adverse cardiovascular events (MACEs) in hypertensive patients of different sexes is unclear. HYPOTHESIS: Sex differences in the relationship between HDL‐C levels and the risk of MACEs among hypertensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaopu, Pei, Junyu, Zheng, Keyang, Hu, Xinqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2021
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119833/ https://www.ncbi.nlm.nih.gov/pubmed/33786851 http://dx.doi.org/10.1002/clc.23606

Ejemplares similares

Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus
por: Xing, Zhenhua, et al.
Publicado: (2020)

Association between admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction
por: Pei, Junyu, et al.
Publicado: (2020)

Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
por: Pei, Junyu, et al.
Publicado: (2023)

Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio as Predictor of First Acute Myocardial Infarction and Major Adverse Cardiovascular Event after Intervention in Young Males
por: Li, Zhao, et al.
Publicado: (2018)

Corrigendum: Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio as Predictor of First Acute Myocardial Infarction and Major Adverse Cardiovascular Event after Intervention in Young Males
Publicado: (2018)

Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease
por: Gu, Jun, et al.
Publicado: (2019)

Hb Levels and Sex Differences in Relation to Short-Term Outcomes in Patients With Acute Myocardial Infarction
por: Pei, Junyu, et al.
Publicado: (2021)

Short‐term and long‐term outcomes of revascularization interventions for patients with severely reduced left ventricular ejection fraction: a meta‐analysis
por: Pei, Junyu, et al.
Publicado: (2020)

Association of Lipoprotein(a) Levels With Incidence of Major Adverse Limb Events
por: Guédon, Alexis F., et al.
Publicado: (2022)

The association of interferon‐alpha with development of collateral circulation after artery occlusion
por: Xing, Zhenhua, et al.
Publicado: (2021)

Association of Coronary Plaque With Low-Density Lipoprotein Cholesterol Levels and Rates of Cardiovascular Disease Events Among Symptomatic Adults
por: Mortensen, Martin Bødtker, et al.
Publicado: (2022)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

High-Density Lipoprotein Cholesterol Efflux Capacity as a Surrogate Marker for Major Cardiac Adverse Events in Japanese Patients
por: Komatsu, Tomohiro, et al.
Publicado: (2021)

The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol
por: Durakoğlugil, Murtaza Emre, et al.
Publicado: (2015)

Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients
por: Kim, Ji Eun, et al.
Publicado: (2019)

The Brain-Heart Connection in Takotsubo Syndrome: The Central Nervous System, Sympathetic Nervous System, and Catecholamine Overload
por: Wang, Xiaopu, et al.
Publicado: (2020)

Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab
por: Desai, Nihar R., et al.
Publicado: (2021)

Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels
por: Sajja, Aparna, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials
por: Vallejo‐Vaz, Antonio J., et al.
Publicado: (2018)

Association between the atherogenic index of plasma and major adverse cardiovascular events among non-diabetic hypertensive older adults
por: Hang, Fei, et al.
Publicado: (2022)

Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults
por: Chiang, Jui-Kun, et al.
Publicado: (2011)

Cost-effectiveness of Financial Incentives for Patients and Physicians to Manage Low-Density Lipoprotein Cholesterol Levels
por: Pandya, Ankur, et al.
Publicado: (2018)

Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension
por: Kopeć, Grzegorz, et al.
Publicado: (2017)

Assessment of Sex Disparities in Nonacceptance of Statin Therapy and Low-Density Lipoprotein Cholesterol Levels Among Patients at High Cardiovascular Risk
por: Brown, C. Justin, et al.
Publicado: (2023)

Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects
por: Zhu, Chen, et al.
Publicado: (2022)

Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III
por: Pechlaner, Raimund, et al.
Publicado: (2017)

Is the variation in monocyte to high-density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome?
por: Figueiredo, E.T., et al.
Publicado: (2023)

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol
por: Colhoun, Helen M., et al.
Publicado: (2020)

Positive association between the ratio of triglycerides to high-density lipoprotein cholesterol and diabetes incidence in Korean adults
por: Kim, Joungyoun, et al.
Publicado: (2021)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events
por: Naami, Robert, et al.
Publicado: (2022)

Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes
por: Lotta, Luca A., et al.
Publicado: (2018)

Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?
por: Li, Chaoyang, et al.
Publicado: (2008)

Association Between Low-Density Lipoprotein Cholesterol Levels and Risk for Sepsis Among Patients Admitted to the Hospital With Infection
por: Feng, QiPing, et al.
Publicado: (2019)

Contribution and interaction of the low‐density lipoprotein cholesterol to high‐density lipoprotein cholesterol ratio and triglyceride to diabetes in hypertensive patients: A cross‐sectional study
por: Hong, Mengyang, et al.
Publicado: (2018)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c7g3euvcfjdjfdaq7ii8ikjfa0